Associate Director, Market Access – Poland and Eastern European Countries

Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health. Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities. Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options. About Commercial Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific. Position: Associate Director, Market Access – Poland and Eastern European Countries Location: Poland (Warsaw preferably) Coverage: Poland, Hungary, Baltic States, Balkans, Czechia, Slovakia, Croatia, others Department: Commercial Team Eastern European Countries Cluster / PAVE (Pricing, Access, Value, Evidence TEAM – Eastern and Northern Europe Market Access) Reports: Area Director, Eastern European Countries, dotted-line to Eastern and Northern Europe Market Access Director Summary: BioMarin, a global leader in biotech medicines for Rare and Ultra‑Rare diseases, is recruiting for a SM/AD Market Access in Eastern European Countries (Poland, Czechia, Slovakia, Hungary, Bulgaria, Romania, Baltic states, Balkans, Greece, Cyprus, Malta). The SM/AD, Market Access – Eastern European Countries (EEC) is responsible for driving, coordinating, and executing all delegated market access–related activities across the assigned countries. The role ensures effective planning and implementation of market access strategies, health‑policy activities, payer engagements, early pipeline/new product planning, and cross‑functional collaboration to support BioMarin’s portfolio. This position works in close alignment with the ENE Market Access team, Medical Affairs, Marketing, and local Commercial teams to secure timely and sustainable access to BioMarin products for patients across diverse healthcare systems. Success in this role requires a highly collaborative, transparent, and solution‑oriented working style to ensure smooth coordination across Commercial and cross‑functional teams. Responsibilities: Market Access Strategy and Execution: Coordinate and deliver all market access activities in the EEC region. Primary focus of activities is in Poland and other Eastern European Countries as prioritised in alignment with the EEC Commercial team and ENE Market Access leadership. Preparation of Pricing and Reimbursement dossiers for different archetypes of markets and health systems, such as HTA markets, budgetary‑driven markets, and Named Patient‑sales markets. Support national and regional reimbursement processes, pricing negotiations, and renewal cycles of contracts and named patient‑sales applications where applicable, in support of Commercial objectives. Ensure consistency of communication and alignment with Global, International, and ENE Market Access, and cross‑functional regional teams (Medical Affairs, Marketing, Legal, Advocacy, Government Affairs, Communications). Payer & Stakeholder Engagement: Identify, map, and prioritise key national, regional, and local stakeholders across assigned countries and institutions. Engage with payers/ex‑payers/agencies toward preparation of HTA submissions, establishing and maintaining credible, long‑term relationships with them. Capture payer needs and insights to inform internal planning on evidence generation, pricing strategies, and market access. Directly or indirectly activate local stakeholders, including trade organisations, HCPs, medical societies, politicians, and representatives from patient advocacy organisations, to create a supportive environment for discussions on rare and ultra‑rare diseases. Access Policy: Continuously monitor the health policy environment, HTA/reimbursement reforms, pricing legislation, and payer trends across the EEC. Liaise with relevant coalitions, trade organisations, and interest groups that operate/work in rare disease. Provide regular briefings and recommendations to the Regional and Global Market Access teams regarding the evolving policy landscape. Influence discussions on policy that benefit access to rare diseases or legitimate BioMarin interests on pricing, HTA, and access. General responsibilities/requirements: Work closely with cross‑functional teams (Medical Affairs, Marketing, Legal, Advocacy, Government Affairs, Communications). Ensure seamless, proactive collaboration with the EEC Commercial team, maintaining continuous alignment on priorities, planning, and execution to support unified regional strategies. Demonstrate transparent, timely communication with all internal stakeholders, ensuring clarity, alignment, and efficient issue resolution across markets. Foster constructive, cross‑functional partnerships built on trust, accountability, and open dialogue. Provide Market Access perspective to cross‑functional brand planning, Commercial goal‑setting, scenario analysis, and strategic or tactical discussions. Contribute to improved positioning of key BioMarin assets in payer recommendations, treatment guidelines, and national/regional formularies. Provide continuous analysis on the evolving payer landscape to inform forward‑looking strategies and internal decision‑making, in preparation for future launches. Ensure all activities adhere to local regulations, laws, and codes of conduct, both EU and national, as well as internal BioMarin SOPs and relevant codes of conduct. Be available for regional travel across the EEC region, and occasional travel to broader European or Global meetings, conferences, and cross‑functional workshops. Education: University degree in Business Administration, Economics, Life Sciences, Medicine, Pharmacy, Biology, Chemistry, or a related field. Advanced degrees in Market Access, Health Economics, Public Health, or Health Policy preferred. Fluency in English required; additional Central/Eastern European languages an advantage. Experience: Several years of experience in the pharmaceutical industry, ideally in: Market Access Health Economics / HTA Health Policy Pricing & Reimbursement Marketing or related commercial functions Strong knowledge of reimbursement frameworks and decision‑making processes in Poland (mandatory) and Central & Eastern Europe. Proven ability to translate, summarise, and communicate clinical and economic evidence into compelling payer value propositions. Experience working with cross‑functional teams and external experts (HTA bodies, payers, KOLs, consultants). Previous regional experience (multi‑country responsibility is a strong advantage). Track record of operating with high accountability, delivering on commitments, and maintaining strong cross‑functional alignment. Personal qualities: Strong team player with excellent interpersonal and communication skills. Collaborative mindset with a mature, low‑ego approach to cross‑functional work. Highly self‑organised, proactive, and able to manage multiple priorities across diverse markets. Transparent communicator, able to maintain alignment and resolve issues constructively. Strategic thinker with strong analytical ability and hands‑on execution mindset. Comfortable navigating ambiguity, diverse regulations, and rapidly evolving payer landscapes. Able and willing to travel flexibly across the region. Leadership Style: Although this role has no formal direct reports at present, the successful candidate must demonstrate strong leadership presence and influence across the region. The ideal leadership style is collaborative, mature, transparent, and solution‑oriented, enabling effective cross‑functional alignment and execution in a complex matrix environment. Key leadership expectations: Builds trust‑based relationships with Commercial, Medical, and Market Access colleagues, ensuring alignment and smooth execution across countries. Models a calm, solutions‑focused approach when navigating challenges, ambiguity, or competing priorities. Drives clarity, structure, and forward momentum, ensuring timely decision‑making and reliable follow‑through. Promotes an open, respectful culture that values collaboration, constructive feedback, and collective problem‑solving. Encourages diverse viewpoints and fosters psychological safety to optimise strategy development and execution. Supervisory responsibility: No direct reports at present; potential future expansion depending on business needs. Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned. Equal Opportunity Employer/Veterans/Disabled An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.